Skip to main content
ConductScienceScienceDex

Mark A Lemmon

NIH Rank #3593
Unclaimed recordClaim profile
  • Program Leader
  • R01 Holder
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 2091948Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pharmacology

NIH Funding · FY2024

Linked Award Amount
$2.5M
Full award amounts, FY2024
Award Records
5
Records listing this PI
Award-Linked Rank
#3,593
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Mark A Lemmon. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Mark A Lemmon as a PI. Multi-PI records show the full award amount for context.

  • 5R35GM122485-08R35
    Understanding Signaling by Non-Canonical Receptor Tyrosine Kinases
    Yale University
    $770.5K
    award amount
  • 5R01CA244660-05R01
    Multiscale Modeling to Optimize Inhibition of Oncogenic ERK Pathway Signaling
    Yale University
    $643.7K
    award amount
  • 5R01CA248166-05R01
    Understanding how receptor tyrosine kinase activation dynamics specify proliferative cellular responses
    Yale University
    $502.3K
    award amount
  • 5R01CA198164-10R01
    Understanding EGF receptor activation by growth factors and oncogenic mutations
    Yale University
    $487.9K
    award amount
  • 5P50DE030707-05P50
    Yale Head and Neck Cancer SPORE: Overcoming Treatment Resistance in Head and Neck Cancer
    Yale University
    $110.8K
    award amount

Award organization

Organizations that administered FY2024 awards listing Mark A Lemmon as a PI.

FY2024 award administered by Yale University (CT).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Yale University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #3593
  6. 2024
    Entered Top 25% Nationally
    Ranked #3593
  7. 2025
    R01 Grant Holder
  8. 2025
    Program/Center Grant Leader

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Mark A Lemmon.

Kathryn M Ferguson
Yale University
2
shared awards
Barbara Burtness
Yale University
1
shared award
Boris N Kholodenko
Yale University
1
shared award
David L Rimm
Yale University
1
shared award
Diane Lidke
Yale University
1
shared award
Jeffrey Peter Townsend
Yale University
1
shared award
Karen S. Anderson
Yale University
1
shared award
Ravi Radhakrishnan
Yale University
1
shared award
Roy Decker
Yale University
1
shared award
William S Hlavacek
Yale University
1
shared award

Explore further

Find collaborators for Mark A Lemmon

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →